Turnover in the last 5 years

Millions EUR

Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2018 to 2022.

Number of employees in total and after education in the last 5 years

People

Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2018 to 2022.

MolPort Inc. was established in 2006 and we are proud to see it becoming an internationally recognized compound sourcing platform.
MolPort was created to take responsibility for both sourcing and procurement, accelerating drug discovery by helping scientists focus on their important research. We assure reliable sourcing of hundreds and thousands of compounds from many trustworthy suppliers, helping scientists in industry, academia, and government institutions worldwide get their compounds in the most cost-effective way and in the format of their choice.
Containing a catalog of all the major chemical suppliers in the world, MolPort was created to provide a consolidated online database for easy and efficient order fulfillment. Offering 100 million SKUs and updated regularly, it is one of the largest databases in Europe catering to drug discovery and consists of commercially available screening compounds, building blocks and virtual compounds. With MolPort’s advanced algorithms in place, we can track compounds when ordered and monitor how well suppliers fulfill your orders. Based on these statistics, we suggest the best way to order compounds such that you receive them at the time and in the format you require.
MolPort was featured in the Financial Times Top 1000 Europe's Fastest Growing Companies 2019 which is an annual list produced by one of the world's leading news organizations.

Main markets

  1. 1. United States
  2. 2. South Korea
  3. 3. Italy
  4. 4. United Kingdom
  5. 5. Poland
  6. 6. Spain
  7. 7. Switzerland
  8. 8. Germany

Target Markets

  1. 1. United States
  2. 2. South Korea
  3. 3. Italy
  4. 4. United Kingdom
  5. 5. Poland
  6. 6. Spain
  7. 7. Switzerland
  8. 8. Germany

Products

R&D research chemicals for laboratory use.

Foundation year: 2006

NACE classifier: 47,91

Turnover in the last 5 years

Millions EUR

Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2018 to 2022.

2018 2019 2020 2021 2022
4100000 4700000 8200000 7792925 n/a

Number of employees in total and after education in the last 5 years

People

Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2018 to 2022.

2018 2019 2020 2021 2022
With higher education 16 22 33 38 n/a
With secondary and professional education n/a n/a n/a n/a n/a
Number of employees in total 16 22 33 38 n/a

Export volume over the last 5 years

Data are not able

Data are not able

Empty chart placeholder

Main markets

  1. 1. United States
  2. 2. South Korea
  3. 3. Italy
  4. 4. United Kingdom
  5. 5. Poland

Target Markets

  1. 1. United States
  2. 2. South Korea
  3. 3. Italy
  4. 4. United Kingdom
  5. 5. Poland
  6. 6. Spain
  7. 7. Switzerland
  8. 8. Germany

Investing in R&D

Data are not able

Data are not able

Empty chart placeholder

MolPort SIA

Description about enterprise:

MolPort Inc. was established in 2006 and we are proud to see it becoming an internationally recognized compound sourcing platform.
MolPort was created to take responsibility for both sourcing and procurement, accelerating drug discovery by helping scientists focus on their important research. We assure reliable sourcing of hundreds and thousands of compounds from many trustworthy suppliers, helping scientists in industry, academia, and government institutions worldwide get their compounds in the most cost-effective way and in the format of their choice.
Containing a catalog of all the major chemical suppliers in the world, MolPort was created to provide a consolidated online database for easy and efficient order fulfillment. Offering 100 million SKUs and updated regularly, it is one of the largest databases in Europe catering to drug discovery and consists of commercially available screening compounds, building blocks and virtual compounds. With MolPort’s advanced algorithms in place, we can track compounds when ordered and monitor how well suppliers fulfill your orders. Based on these statistics, we suggest the best way to order compounds such that you receive them at the time and in the format you require.
MolPort was featured in the Financial Times Top 1000 Europe's Fastest Growing Companies 2019 which is an annual list produced by one of the world's leading news organizations.

Products

R&D research chemicals for laboratory use.